Annual CFI
-$43.40 M
+$65.84 M+60.27%
December 31, 2023
Summary
- As of February 8, 2025, ORIC annual cash flow from investing activities is -$43.40 million, with the most recent change of +$65.84 million (+60.27%) on December 31, 2023.
- During the last 3 years, ORIC annual CFI has risen by +$172.56 million (+79.90%).
- ORIC annual CFI is now -127.39% below its all-time high of $158.44 million, reached on December 31, 2021.
Performance
ORIC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$23.07 M
+$4.79 M+26.20%
September 30, 2024
Summary
- As of February 8, 2025, ORIC quarterly cash flow from investing activities is $23.07 million, with the most recent change of +$4.79 million (+26.20%) on September 30, 2024.
- Over the past year, ORIC quarterly CFI has increased by +$80.90 million (+139.89%).
- ORIC quarterly CFI is now -71.99% below its all-time high of $82.36 million, reached on June 30, 2021.
Performance
ORIC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$445.00 K
+$80.90 M+100.55%
September 30, 2024
Summary
- As of February 8, 2025, ORIC TTM cash flow from investing activities is $445.00 thousand, with the most recent change of +$80.90 million (+100.55%) on September 30, 2024.
- Over the past year, ORIC TTM CFI has increased by +$36.51 million (+101.23%).
- ORIC TTM CFI is now -99.72% below its all-time high of $158.44 million, reached on December 31, 2021.
Performance
ORIC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ORIC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.3% | +139.9% | +101.2% |
| 3 y3 years | +79.9% | +139.9% | +101.2% |
| 5 y5 years | -8443.9% | +139.9% | +101.2% |
ORIC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -127.4% | +60.3% | -18.5% | +125.5% | -99.7% | +100.3% |
| 5 y | 5-year | -127.4% | +79.9% | -72.0% | +118.5% | -99.7% | +100.2% |
| alltime | all time | -127.4% | +79.9% | -72.0% | +118.5% | -99.7% | +100.2% |
ORIC Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $23.07 M(+26.2%) | $445.00 K(-100.6%) |
| Jun 2024 | - | $18.28 M(-129.5%) | -$80.46 M(-31.8%) |
| Mar 2024 | - | -$61.87 M(-395.1%) | -$118.05 M(+172.0%) |
| Dec 2023 | -$43.40 M(-60.3%) | $20.96 M(-136.2%) | -$43.40 M(+20.3%) |
| Sep 2023 | - | -$57.83 M(+199.4%) | -$36.07 M(-271.1%) |
| Jun 2023 | - | -$19.31 M(-251.1%) | $21.08 M(-462.8%) |
| Mar 2023 | - | $12.78 M(-54.8%) | -$5.81 M(-94.7%) |
| Dec 2022 | -$109.25 M(-169.0%) | $28.30 M(-4231.4%) | -$109.25 M(-20.4%) |
| Sep 2022 | - | -$685.00 K(-98.5%) | -$137.20 M(+35.2%) |
| Jun 2022 | - | -$46.20 M(-49.0%) | -$101.44 M(-473.9%) |
| Mar 2022 | - | -$90.66 M(<-9900.0%) | $27.13 M(-82.9%) |
| Dec 2021 | $158.44 M | $351.00 K(-99.0%) | $158.44 M(+137.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $35.07 M(-57.4%) | $66.83 M(-171.9%) |
| Jun 2021 | - | $82.36 M(+102.6%) | -$92.93 M(-47.0%) |
| Mar 2021 | - | $40.65 M(-144.5%) | -$175.50 M(-18.7%) |
| Dec 2020 | -$215.96 M(>+9900.0%) | -$91.26 M(-26.8%) | -$215.96 M(+73.1%) |
| Sep 2020 | - | -$124.69 M(>+9900.0%) | -$124.76 M(>+9900.0%) |
| Jun 2020 | - | -$202.00 K(-206.9%) | -$288.00 K(-39.9%) |
| Mar 2020 | - | $189.00 K(-437.5%) | -$479.00 K(-37.6%) |
| Dec 2019 | -$768.00 K(+51.2%) | -$56.00 K(-74.4%) | -$768.00 K(+7.9%) |
| Sep 2019 | - | -$219.00 K(-44.3%) | -$712.00 K(+44.4%) |
| Jun 2019 | - | -$393.00 K(+293.0%) | -$493.00 K(+393.0%) |
| Mar 2019 | - | -$100.00 K | -$100.00 K |
| Dec 2018 | -$508.00 K | - | - |
FAQ
- What is ORIC Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual CFI year-on-year change?
- What is ORIC Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly CFI year-on-year change?
- What is ORIC Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals TTM CFI year-on-year change?
What is ORIC Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ORIC is -$43.40 M
What is the all time high annual CFI for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual cash flow from investing activities is $158.44 M
What is ORIC Pharmaceuticals annual CFI year-on-year change?
Over the past year, ORIC annual cash flow from investing activities has changed by +$65.84 M (+60.27%)
What is ORIC Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ORIC is $23.07 M
What is the all time high quarterly CFI for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly cash flow from investing activities is $82.36 M
What is ORIC Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ORIC quarterly cash flow from investing activities has changed by +$80.90 M (+139.89%)
What is ORIC Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ORIC is $445.00 K
What is the all time high TTM CFI for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high TTM cash flow from investing activities is $158.44 M
What is ORIC Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ORIC TTM cash flow from investing activities has changed by +$36.51 M (+101.23%)